Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness Between Daily Versus Pulse Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients: A Randomized Controlled Trial and Multicenter Study

NCT02895061 is registered in ClinicalTrials.gov with Phramongkutklao College of Medicine and Hospital as lead sponsor.

NCT NCT02895061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02895061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness Between Daily Versus Pulse Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients: A Randomized Controlled Trial and Multicenter Study
Lead sponsor
Phramongkutklao College of Medicine and Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
January 31, 2016
Enrollment
502 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alfacalcidol, secondary hyperparathyroidism, hemodialysis